BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18928611)

  • 1. [Immune reconstitution after allogeneic peripheral blood stem cell transplantation].
    Hong M; Li JY; Qian SX; Wu HX; Lu H; Zhang R; Zhang XY; Xu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1130-4. PubMed ID: 18928611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of immunological reconstitution and related complications after HLA-matched and HLA haploidentical peripheral blood hematopoietic stem cell transplantation].
    Li L; Yuan HL; Wen BZ; Zhong D; Qu JH; Jiang M; Halida Y; Guo XH; Hao JP
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):204-7. PubMed ID: 20450650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
    Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative analysis of early reconstitution of T-lymphocyte subsets and T-cell receptor excision cycles in patients after myeloablative unrelated cord blood and sibling donor transplantation].
    Nie H; Wang J; Lu YJ; Zheng CC; Tang BL; Yao W; Zhu XY; Qiang P; Zhang L; Liu HL; Sun ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):440-6. PubMed ID: 24763020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between immune reconstitution and chronic graft-versus-host disease after unrelated cord blood transplantation and sibling peripheral blood stem cell transplantation].
    Wang J; Pan TZ; Huang PP; Sun ZM; Zhu HP
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):466-473. PubMed ID: 34384152
    [No Abstract]   [Full Text] [Related]  

  • 6. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of T lymphocyte absolute number and function in the early phase after haploidentical hematopoietic stem cell transplantation].
    Ding L; Dong L; Zheng XL; Lin SS; Zhu H; Wang ZD; Yan HM; Guo ZK; Wang HX; Wu ZZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):702-6. PubMed ID: 23815926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in peripheral lymphocyte subfraction in cytomegalovirus infections during the early stage of allogenic peripheral blood stem cell transplantation].
    Li TS; Qin HY; Chen H; Jiang M; Wang HL; Wang AX
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):396-9. PubMed ID: 12895323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repopulation of circulating T, B and NK lymphocytes following bone marrow and blood stem cell transplantation.
    Parrado A; Casares S; Prieto J; Carmona M; Vaquero A; Rodríguez-Fernández JM
    Hematol Cell Ther; 1997 Dec; 39(6):301-6. PubMed ID: 9497889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of CD34(+) cells and T cells subsets in grafts on prognosis of HLA-identical sibling allogeneic peripheral blood stem cell transplantation].
    Zhou Z; Wang M; He Y
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):819-23. PubMed ID: 19176036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
    Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
    Ashihara E; Shimazaki C; Yamagata N; Hirata T; Okawa K; Oku N; Goto H; Inaba T; Fujita N; Nakagawa M
    Bone Marrow Transplant; 1994 Apr; 13(4):377-81. PubMed ID: 7912603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
    Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).
    Reimer P; Kunzmann V; Wilhelm M; Weissbrich B; Kraemer D; Berghammer H; Weissinger F
    Ann Hematol; 2003 May; 82(5):263-70. PubMed ID: 12739062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.
    Dodero A; Carrabba M; Milani R; Rizzo E; Raganato A; Montefusco V; Farina L; Milanesi M; Longoni P; Carlo-Stella C; Corradini P
    Exp Hematol; 2005 Aug; 33(8):920-7. PubMed ID: 16038785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
    Martínez C; Urbano-Ispizua A; Rozman C; Marín P; Rovira M; Sierra J; Montfort N; Carreras E; Montserrat E
    Exp Hematol; 1999 Mar; 27(3):561-8. PubMed ID: 10089920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT.
    Scholl S; Mügge LO; Issa MC; Kasper C; Pachmann K; Höffken K; Sayer HG
    Bone Marrow Transplant; 2005 Jan; 35(2):183-90. PubMed ID: 15531897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
    Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.